By Tania S. Smith. Updated May 8, 2019 "Thyroid pharmaceutical prejudice" is simply a bias against one thyroid hormone pharmaceutical type in favor of another. Prejudice claims that a particular thyroid medication is intrinsically unsafe or ineffective, for all patients under almost all circumstances. It's a type of "sweeping generalization" fallacy. The main aim of … Continue reading Thyroid pharmaceutical prejudice: How it works
Category: American Thyroid Association
Biondi and Wartofsky’s 2014 dismissal of desiccated thyroid
Bernadette Biondi and Leonard Wartofsky's article in 2014 titled "Treatment with Thyroid Hormone" summarily dismisses the use of desiccated thyroid medication in thyroid therapy. Tracing the logic of their dismissal back to their citation, a 1980 research article, reveals a fallacious chain of argument based on a very thin foundation. This pathway of reasoning promotes … Continue reading Biondi and Wartofsky’s 2014 dismissal of desiccated thyroid
VIDEO: What’s wrong with therapy for hypothyroidism?
On December 17, I decided to purchase "Doodly" video creation software that was being advertised on Facebook, and I made this 10-minute educational video. It is meant to raise an appropriate sense of alarm at the problems with thyroid therapy and to offer some possible solutions. Clicking the title image will take you to YouTube to … Continue reading VIDEO: What’s wrong with therapy for hypothyroidism?
The ATA is worried about doctors prescribing T3/T4 combo therapy
Here, I comment on a brief October 2018 article in a journal of the American Thyroid Association -- the association that writes the guidelines that dismisses Free T3 testing and T3/T4 therapy. Link: https://www.liebertpub.com/doi/full/10.1089/ct.2018%3B30.523-525 This article shows the leading endocrinologists are getting worried about doctors not adhering to guidelines. They did a study that showed … Continue reading The ATA is worried about doctors prescribing T3/T4 combo therapy
Why T4 monotherapy has dominated
All thyroid hormone medications have the potential to be effective: L-T4 (Levothyroxine), L-T3 (Liothyronine), and natural desiccated thyroid (DTE / NDT). However, each patient is unique in their response to these medications. Optimizing a patient's lifelong therapy involves finding the right thyroid hormone medication, or a combination of them, to relieve as many symptoms of … Continue reading Why T4 monotherapy has dominated